Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  Encompass Health Corporation    EHC


News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

ENCOMPASS HEALTH CORP : Regulation FD Disclosure (form 8-K)

share with twitter share with LinkedIn share with facebook
05/19/2020 | 08:14am EDT

Item 7.01. Regulation FD Disclosure.

Encompass Health Corporation ("Encompass Health" or the "Company") will participate in the UBS Virtual Global Healthcare Conference being held May 18-20, 2020. Encompass Health President and Chief Executive Officer Mark Tarr and Executive Vice President and Chief Financial Officer Doug Coltharp will participate in a fireside chat at 10:00 a.m. ET on Tuesday, May 19, 2020. The fireside chat will be webcast live and will be available at http://investor.encompasshealth.com by clicking on an available link. The Company is providing certain current volume observations for both of its segments. For the month of April 2020, the Company is providing certain year-over-year volume growth information for all of its business lines, as follows: • Inpatient rehabilitation total discharges decreased 20.9%

• Home health total admissions decreased 23.5%

• Hospice total admissions increased 27.8%

            Inpatient Rehabilitation - Patient Census Information
                                  April 12, 2020

February 29, 2020March 31, 2020 (Easter Weekend) April 29, 2020May 13, 2020

      6,782           5,342           5,139           5,989         6,233

Home Health - Starts of Episodes (Includes Starts of Care and Recertifications)

   Week Ended       Week Ended        Week Ended        Week Ended      Week Ended
 March 1, 2020    March 29, 2020    April 12, 2020    April 26, 2020   May 10, 2020
     4,950             4,778             4,120             4,283          4,995

                         Hospice - Admissions

Week Ended Week Ended Week Ended Week Ended Week Ended March 1, 2020March 29, 2020April 12, 2020April 26, 2020May 10, 2020

     259           197            236            239           235

The information contained herein is being furnished pursuant to Item 7.01 of
Form 8-K, "Regulation FD Disclosure." This information shall not be deemed
"filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or incorporated by reference in any filing under
the Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by specific reference in such a filing. The furnishing of
this information will not be deemed an admission as to the materiality of any
information contained herein.
Forward-Looking Statements
Certain statements in this Current Report on Form 8-K and the fireside chat
constitute forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements are
subject to various risks and uncertainties and include all statements that are
not historical statements of fact and those regarding the Company's intent,
belief or expectations, including statements and assumptions regarding the
nature of the COVID-19 pandemic, its impact on the Company's results of
operations, cash flow and liquidity, actions to be taken by the Company in
response to the pandemic, and the demand for the Company's services. These
forward-looking statements are based on certain assumptions and expectations,
and the Company's ability to predict results or the actual effect of future
actions, plans or strategies, or the spread and impact of COVID-19 is inherently
uncertain. Actual results and performance could differ materially. Factors which
could have a material adverse effect on the Company's operations and future
prospects or which could cause events or circumstances to differ from the
forward-looking statements include, but are not limited to, the continued spread
of COVID-19, including the speed, depth, geographic reach and duration of the
spread, which could decrease our patient volumes and revenues and lead to
staffing and supply shortages and associated cost increases; actions to be taken
by the Company in response to the pandemic; the legal, regulatory and
administrative developments that occur at the federal, state and local levels;
the Company's infectious disease prevention and control efforts; the demand for
the Company's services, including based on any downturns in the economy,
consumer confidence, or the capital markets and unemployment among family
members; the Company's ability to attract and retain nurses, therapists, and
other healthcare


professionals in a highly competitive environment with often severe staffing shortages, which may be worsened by the pandemic, and the impact on the Company's labor expenses from potential union activity and staffing shortages; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of the Company's or its vendors' or partners' information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information or inability to provide patient care because of system unavailability; the Company's ability to comply with extensive, complex, and ever-changing federal, state and local regulations and sub-regulatory guidance in both business in general, such as privacy and wage and hour regulations, and the healthcare industry specifically; any adverse outcome of various lawsuits, claims, and legal or regulatory proceedings involving the Company, including any matters related to yet undiscovered issues, if any, in acquired operations; the Company's ability to attract and retain key management personnel; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for the Company's services by governmental or private payors; changes in the regulation of the healthcare industry at either or both of the federal and state levels (such as the Patient-Driven Groupings Model for home health, the new patient assessment measures, which we refer to as "Section GG functional measures," for inpatient rehabilitation, and other payment system reforms) and the Company's ability to adapt operations to those changes; the Company's ability to control costs, particularly labor and employee benefit costs, including group medical expenses; the Company's ability to maintain proper local, state and federal licensing, including compliance with the Medicare conditions of participation and provider enrollment requirements, which is required to participate in the Medicare program; and changes in the Company's payor mix or the acuity of its patients affecting reimbursement rates as well as other risks detailed from time to time in Encompass Health'sSEC filings and other public announcements, including its Form 10­K for the year ended December 31, 2019 and Form 10-Q for the quarter ended March 31, 2020. When considering forward-looking statements, readers should keep in mind the risk factors and other cautionary statements in such SEC filings. Readers are cautioned not to place undue reliance on any of these forward-looking statements, which reflect management's views as of the date of this presentation. The Company cannot guarantee future results, levels of activity, performance or achievements, and, except as required by law, it expressly disclaims any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations with regard thereto or change in events, conditions or circumstances on which any statement is based.


© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
07/01POWERED BY CARE : What hospital leader Jennifer Hinds is seeing in the time of C..
07/01ENCOMPASS HEALTH : and Covenant Health announce joint venture in Knoxville, Tenn..
07/01ENCOMPASS HEALTH : and Covenant Health announce joint venture to own and operate..
06/30ENCOMPASS HEALTH CORPORATION : Ex-dividend day for
06/29ENCOMPASS HEALTH : Enhancing collaboration of care through care transitions
06/29ENCOMPASS HEALTH : The world is changing—the need for our services is not
06/24ENCOMPASS HEALTH : announces date of 2020 second quarter conference call
06/22ENCOMPASS HEALTH CORP : Regulation FD Disclosure (form 8-K)
06/17POWERED BY CARE : The role of a director of therapy operations
06/15ENCOMPASS HEALTH : opens its first rehabilitation hospital in South Dakota
More news